MS Patient Dies From Anti-Drug Antibodies MedPage Today Point out that the authors recommend that repeated moderate to severe infusion reactions in the beginning of natalizumab treatment should prompt the cessation of treatment and assessment for the development of natalizumab anti-drug antibodies. A ... |
